Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Allergan Plc (AGN)

Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Virios Therapeutics Up 75% on Fibromyalgia Phase 3 Proposal

Virios Therapeutics Inc. (NASDAQ: VIRI) is a developmental-stage biotechnology company specializing in novel antiviral therapies for treating fibromyalgia

VIRI : 0.1550 (+12.40%)
AGN : 193.02 (+0.02%)
LLY : 753.41 (+3.25%)
PFE : 24.94 (-0.64%)
GPS : 24.55 (+4.38%)
Is the Pain Over for Baudax Bio Investors after a 70% Spike?

Baudax Bio (NASDAQ: BXRX) shares spiked as much as 70% on its announcement of positive interim phase 2 clinical trials for its pain medicine BX1000.

BXRX : 0.0218 (+7.39%)
ABBV : 167.76 (+0.71%)
PFE : 24.94 (-0.64%)
AGN : 193.02 (+0.02%)
MRK : 97.44 (+0.93%)
Aegon NV: Q3 Earnings Snapshot

Aegon NV: Q3 Earnings Snapshot

AGN : 193.02 (+0.02%)
AEG : 6.24 (-1.42%)
Judge: Walgreens contributed to San Francisco opioid crisis

SAN FRANCISCO (AP) — A federal judge ruled Wednesday that Walgreens can be held responsible for contributing to San Francisco's opioid crisis for over-dispensing highly addictive drugs for years without...

AGN : 193.02 (+0.02%)
States reach deal over marketing, safety of generic opioids

HARRISBURG, Pa. (AP) — A former opioid manufacturer has agreed in principle to pay up to $2.4 billion in a deal with a dozen states over its marketing and product safety practices, state attorneys general...

MCK : 621.14 (+0.89%)
CAH : 120.34 (+1.70%)
AGN : 193.02 (+0.02%)
JNJ : 153.11 (+0.07%)
WVa opioid trial verdict still pending nearly a year later

CHARLESTON, W.Va. (AP) — Last July, a federal judge in West Virginia in the first lawsuit to go to trial over the U.S. opioid addiction epidemic.

MCK : 621.14 (+0.89%)
CAH : 120.34 (+1.70%)
AGN : 193.02 (+0.02%)
Tentative $161.5M settlement reached in WVa opioid trial

CHARLESTON, W.Va. (AP) — Attorneys for the state of West Virginia and two remaining pharmaceutical manufacturers have reached a tentative $161.5 million settlement just as closing arguments were set...

MCK : 621.14 (+0.89%)
CAH : 120.34 (+1.70%)
JNJ : 153.11 (+0.07%)
AGN : 193.02 (+0.02%)
Walgreens, Florida settle opioid costs lawsuit for $683M

ST. PETERSBURG, Fla. (AP) — The Walgreens pharmacy chain has reached a $683 million settlement with the state of Florida in a lawsuit accusing the company of improperly dispensing millions of painkillers...

AGN : 193.02 (+0.02%)
CAH : 120.34 (+1.70%)
1 drug company settles ahead of San Francisco opioid trial

SAN FRANCISCO (AP) — Drugmaker Endo Pharmaceuticals has agreed to pay the city of San Francisco $10 million over its role in selling prescription opioids in the city.

AGN : 193.02 (+0.02%)
J&J's Janssen settles with WVa for $99M in opioid lawsuit

CHARLESTON, W.Va. (AP) — West Virginia will receive $99 million in a settlement finalized Monday with Johnson & Johnson's subsidiary Janssen Pharmaceuticals Inc. over in the state that has long led...

$SPX : 5,917.11 (unch)
$DOWI : 43,408.47 (+0.32%)
$IUXX : 20,667.10 (-0.08%)
CAH : 120.34 (+1.70%)
AGN : 193.02 (+0.02%)
JNJ : 153.11 (+0.07%)

Barchart Exclusives

Using Option To Generate Extra Income From Your Bond Investments
With markets looking increasingly volatile, investors might be more interested in generating income rather than capital gains. Bond investments have seen significant capital losses in recent months as inflation concerns continue to have investors anxious. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar